文献速递冠心病外科

糖尿病患者双乳内动脉的使用:是友还是敌?

Bilateral Internal Mammary Artery Use in Diabetic Patients: Friend or Foe?
PubMed 文献 · Ann Thorac Surg · 2018-06-20

本研究基于马里兰州10个心脏外科质量倡议中心2011年7月至2016年6月的单纯冠状动脉旁路移植术患者数据,采用倾向性评分匹配比较糖尿病与非糖尿病双乳内动脉(BIMA)患者、以及糖尿病BIMA与糖尿病左乳内动脉(LIMA)患者的结局。结果显示糖尿病BIMA患者较非糖尿病BIMA患者及糖尿病LIMA患者具有更高的复合并发症/死亡、再次手术、卒中、肾衰竭和延长通气的观察/期望(O/E)比值。

要点

  • 糖尿病BIMA患者较非糖尿病BIMA患者复合并发症/死亡、再次手术、卒中、肾衰竭和延长通气的O/E比值均>1.0,但非糖尿病BIMA患者手术死亡O/E比值更高。
  • 糖尿病BIMA患者较糖尿病LIMA患者复合并发症/死亡、手术死亡、卒中、肾衰竭和延长通气的O/E比值更高。
  • 糖尿病患者接受BIMA移植后主要并发症的O/E比值升高,导致复合并发症/死亡O/E比值更高。

核心结论

  • 在本州范围分析中,接受BIMA移植的糖尿病患者(与接受LIMA移植的糖尿病患者或接受BIMA移植的非糖尿病患者相比)因主要并发症O/E比值更高而具有更高的复合并发症/死亡O/E比值。

研究设计与样本

  • 回顾性多中心队列研究,纳入2011年7月至2016年6月在马里兰州10个心脏外科质量倡议中心接受单纯冠状动脉旁路移植术的患者,对16个变量进行倾向性评分,糖尿病BIMA患者按1:1最近邻匹配分别与非糖尿病BIMA患者和糖尿病LIMA患者匹配。

主要发现

  • 研究期间812例冠状动脉旁路移植术患者接受BIMA移植,其中302例(37%)患有糖尿病;匹配了259对糖尿病与非糖尿病BIMA患者,以及292对糖尿病BIMA与糖尿病LIMA患者。
  • 匹配的糖尿病BIMA患者较非糖尿病BIMA患者复合并发症/死亡、再次手术、卒中、肾衰竭和延长通气的O/E比值均>1.0,但非糖尿病BIMA患者手术死亡O/E比值更高。
  • 糖尿病BIMA患者较糖尿病LIMA患者复合并发症/死亡、手术死亡、卒中、肾衰竭和延长通气的O/E比值更高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bilateral internal mammary artery (BIMA) grafting in diabetic patients undergoing coronary artery bypass grafting remains controversial. Our study compared morbidity and mortality between (1) diabetic and nondiabetic BIMA patients and (2) diabetic BIMA versus diabetic patients who underwent left internal mammary artery (LIMA) grafting only. METHODS: Patients who underwent isolated coronary artery bypass grafting from July 2011 to June 2016 at any of the 10 Maryland Cardiac Surgery Quality Initiative centers were propensity scored across 16 variables. Diabetic BIMA patients were matched 1:1 by nearest neighbor matching to nondiabetic BIMA patients and were separately matched 1:1 to diabetic LIMA patients. We calculated observed-to-expected (O/E) ratios for composite morbidity/mortality, operative mortality, unplanned reoperation, stroke, renal failure, prolonged ventilation, and deep sternal wound infection and compared ratios among matched populations. RESULTS: During the study period, 812 coronary artery bypass grafting patients received BIMA grafts, including 302 patients (37%) with diabetes. We matched 259 diabetic and nondiabetic BIMA patients. O/E ratios were higher in matched diabetic (versus nondiabetic) BIMA patients when comparing composite morbidity/mortality, reoperation, stroke, renal failure, and prolonged ventilation (all O/E ratios >1.0); however, the O/E ratio for operative mortality was higher in nondiabetic BIMA patients. We additionally matched 292 diabetic BIMA to diabetic LIMA patients. Diabetic BIMA patients had a higher O/E ratio for composite morbidity/mortality, operative mortality, stroke, renal failure, and prolonged ventilation. CONCLUSIONS: In this statewide analysis, diabetic patients who received BIMA grafts (compared with diabetic patients with LIMA grafts or nondiabetic patients with BIMA grafts) had higher O/E ratios for composite morbidity/mortality as a result of higher O/E ratios for major complications.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Crawford TC, Zhou X, Fraser CD, et al. Bilateral Internal Mammary Artery Use in Diabetic Patients: Friend or Foe? Ann Thorac Surg. 2018. PMID: 29758209. doi:10.1016/j.athoracsur.2018.04.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。